Imagion Biosystems Limited
Imagion Biosystems Limited
Your view on IBX.AX
Overview
What the company does, where it operates, and who runs it.
About Imagion Biosystems Limited
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Robert Romeo Proulx
- Headquarters
- Suite 2, Melbourne, VIC, AU
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Robert Romeo Proulx
- Headquarters
- Suite 2, Melbourne, VIC, AU
Imagion Biosystems Limited operates as a medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases in Australia. The company is involved in nanotechnology; biotechnology; medical imaging using magnetic resonance; and cancer diagnostics businesses.
It develops MagSense, which is in Phase 2 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, an iron oxide nanoparticle to magnetic relaxometry.
The company has collaboration agreement with Wayne State University to develop optimised MRI sequences which is in Phase 2 study of for the MagSense imaging agent. Imagion Biosystems Limited was incorporated in 2016 and is based in Melbourne, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Imagion Biosystems Limited. Starting points for Imagion Biosystems Limited: EPS -AUD 0.0094, beta -0.21 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Imagion Biosystems Limited. Imagion Biosystems Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Imagion Biosystems Limited. Trailing twelve-month EPS for Imagion Biosystems Limited stands at -AUD 0.0094. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Imagion Biosystems Limited. Imagion Biosystems Limited has reported as a listed company since 2017. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| 1AD.AXAdAlta Limited | Healthcare | Biotechnology | — | ||
| ACR.AXAcrux Limited | Healthcare | Biotechnology | — | ||
| BIT.AXBiotron Limited | Healthcare | Biotechnology | — | ||
| GLH.AXGlobal Health Limited | Healthcare | Medical - Care Facilities | — | ||
| HIQ.AXHITIQ Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| IVX.AXInvion Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| OAK.AXOakridge International Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| VRCDFVerici Dx plc | Healthcare | OTC | $4.5M | ||
| WATWaters Corporation | Healthcare | NYSE | $45.8B | ||
| WGSGeneDx Holdings Corp. | Healthcare | NASDAQ | $1.6B | ||
| WUXAYWuXi AppTec Co., Ltd. | Healthcare | OTC | $45.6B | ||
| WUXIFWuXi AppTec Co., Ltd. | Healthcare | OTC | $39.8B | ||
| XGNExagen Inc. | Healthcare | NASDAQ | $99.5M | ||
| SKHHYSonic Healthcare Limited | Healthcare | OTC | $8.2B | ||
| SLDXStella Diagnostics Inc. | Healthcare | OTC | $1.4M | ||
| SPDESpeedus Corp. | Healthcare | OTC | $416 | ||
| SZLSFStageZero Life Sciences Ltd. | Healthcare | OTC | $61,766 | ||
| TDSGFTelo Genomics Corp. | Healthcare | OTC | $3.8M | ||
| TELO.VTelo Genomics Corp. | Healthcare | TSXV | $4.0M | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Imagion Biosystems Limited.